CFR Pharmaceuticals Announces Exemption From the Takeover Regulation Panel ("TRP") and Confirmation That the Termination Agreement Concluded on 7 February 2014 ("Termination Agreement") is Now Effective
February 13, 2014 09:30 ET
|
CFR Pharmaceuticals
SANTIAGO, Chile, Feb. 13, 2014 (GLOBE NEWSWIRE) -- CFR Pharmaceuticals S.A. (SSE:CFR), the Chilean multinational emerging markets pharmaceutical company, leader in specialties and prescription...
Joint Announcement Regarding the Intended Consensual Termination of the Transaction Implementation Agreement ("TIA") Between Adcock Ingram and CFR Pharmaceuticals ("The Parties")
February 07, 2014 10:07 ET
|
CFR Pharmaceuticals
SANTIAGO, Chile, Feb. 7, 2014 (GLOBE NEWSWIRE) -- CFR Pharmaceuticals S.A. (SSE: CFR), the Chilean multinational emerging markets pharmaceutical company, leader in specialties and prescription...
CFR Announces Further Extension to the Date for Fulfilment or Waiver of the Pre-Conditions to the Revised Scheme Consideration
January 20, 2014 14:06 ET
|
CFR Pharmaceuticals
SANTIAGO, Chile, Jan. 20, 2014 (GLOBE NEWSWIRE) -- Shareholders of CFR and Adcock Ingram are referred to the joint announcement ("Revised Scheme Consideration Announcement") released by Adcock Ingram...
Joint Announcement Regarding a Notice From CFR Pharmaceuticals S.A. ("CFR") ("CFR Notice") to Increase the Total Consideration Payable to the Holders of Adcock Ingram Ordinary Shares in Terms of the Scheme of Arrangement Proposed Between Adcock Ingram and Adcock Ingram Ordinary Shareholders (Other Than the Ordinary Shares Held by Adcock Ingram's Wholly Owned Subsidiary); a Recommendation to Adjourn the General Meetings Scheduled to Take Place on Wednesday, 18 December 2013; the Intention to Oppose the Complaints Set Out in the Application Brought by a Consortium Led by the Bidvest Group Limited ("Bidvest") ("Bidvest Application"); and Renewal of Cautionary Announcement
December 13, 2013 18:28 ET
|
CFR Pharmaceuticals
SANTIAGO, Chile, Dec. 13, 2013 (GLOBE NEWSWIRE) -- CFR Pharmaceuticals S.A. (SSE:CFR), the Chilean multinational emerging markets pharmaceutical company, leader in specialties and prescription...
Distribution of Circular to Adcock Ingram Shareholders in Respect of a Scheme of Arrangement and Posting of CFR Combined Prospectus and Pre-Listing Statement
November 19, 2013 12:12 ET
|
CFR Pharmaceuticals
SANTIAGO, Chile, Nov. 19, 2013 (GLOBE NEWSWIRE) -- CFR Pharmaceuticals S.A. (SSE:CFR), the Chilean multinational emerging markets pharmaceutical company, leader in specialties and prescription...
Announcement of a Firm Intention by CFR Pharmaceuticals to Acquire 100% of the Issued Share Capital of Adcock Ingram by Way of a Scheme of Arrangement
November 15, 2013 08:02 ET
|
CFR Pharmaceuticals
SANTIAGO, Chile, Nov. 15, 2013 (GLOBE NEWSWIRE) -- CFR Pharmaceuticals S.A. (SSE:CFR), the Chilean multinational emerging markets pharmaceutical company, leader in specialities and prescription...
CFR Pharmaceuticals S.A. Announces Consolidated Results for the Third Quarter 2013
November 14, 2013 06:20 ET
|
CFR Pharmaceuticals
SANTIAGO, Chile, Nov. 14, 2013 (GLOBE NEWSWIRE) -- CFR Pharmaceuticals S.A. "the Company" or "CFR", a leading multinational pharmaceutical company focused on branded specialty products, complex...